{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T01:35:34Z","timestamp":1776735334805,"version":"3.51.2"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["R00GM135488"],"award-info":[{"award-number":["R00GM135488"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Digit. Med."],"DOI":"10.1038\/s41746-025-01705-z","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T18:25:29Z","timestamp":1748111129000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Advancing efficacy prediction for electronic health records based emulated trials in repurposing heart failure therapies"],"prefix":"10.1038","volume":"8","author":[{"given":"Nansu","family":"Zong","sequence":"first","affiliation":[]},{"given":"Shaika","family":"Chowdhury","sequence":"additional","affiliation":[]},{"given":"Shibo","family":"Zhou","sequence":"additional","affiliation":[]},{"given":"Sivaraman","family":"Rajaganapathy","sequence":"additional","affiliation":[]},{"given":"Yue","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Liewei","family":"Wang","sequence":"additional","affiliation":[]},{"given":"Qiying","family":"Dai","sequence":"additional","affiliation":[]},{"given":"Pengyang","family":"Li","sequence":"additional","affiliation":[]},{"given":"Xiaoke","family":"Liu","sequence":"additional","affiliation":[]},{"given":"Suzette J.","family":"Bielinski","sequence":"additional","affiliation":[]},{"given":"Jun","family":"Chen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9359-6525","authenticated-orcid":false,"given":"Yongbin","family":"Chen","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-178X","authenticated-orcid":false,"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"key":"1705_CR1","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1016\/j.jacc.2017.08.074","volume":"70","author":"KS Shah","year":"2017","unstructured":"Shah, K. S. et al. Heart failure with preserved, borderline, and reduced ejection fraction. J. Am. Coll. Cardiol. 70, 2476\u20132486 (2017).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1705_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1002\/ejhf.1858","volume":"22","author":"A Groenewegen","year":"2020","unstructured":"Groenewegen, A., Rutten, F. H., Mosterd, A. & Hoes, A. W. Epidemiology of heart failure. Eur. J. heart Fail. 22, 1342\u20131356 (2020).","journal-title":"Eur. J. heart Fail."},{"key":"1705_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.12793\/tcp.2019.27.2.59","volume":"27","author":"K Park","year":"2019","unstructured":"Park, K. A review of computational drug repurposing. Transl. Clin. Pharmacol. 27, 59\u201363 (2019).","journal-title":"Transl. Clin. Pharmacol."},{"key":"1705_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/med.21728","volume":"41","author":"X Wang","year":"2021","unstructured":"Wang, X. & Guan, Y. COVID-19 drug repurposing: a review of computational screening methods, clinical trials, and protein interaction assays. Med. Res. Rev. 41, 5\u201328 (2021).","journal-title":"Med. Res. Rev."},{"key":"1705_CR5","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1080\/17460441.2020.1704729","volume":"15","author":"A Talevi","year":"2020","unstructured":"Talevi, A. & Bellera, C. L. Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics. Expert Opin. Drug Discov. 15, 397\u2013401 (2020).","journal-title":"Expert Opin. Drug Discov."},{"key":"1705_CR6","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1161\/CIRCULATIONAHA.120.051718","volume":"143","author":"JM Franklin","year":"2021","unstructured":"Franklin, J. M. et al. Emulating randomized clinical trials with nonrandomized real-world evidence studies: first results from the RCT DUPLICATE initiative. Circulation 143, 1002\u20131013 (2021).","journal-title":"Circulation"},{"key":"1705_CR7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1177\/17407745231193137","volume":"20","author":"JD Wallach","year":"2023","unstructured":"Wallach, J. D. et al. Assessing the use of observational methods and real-world data to emulate ongoing randomized controlled trials. Clin. Trials 20, 689\u2013698 (2023).","journal-title":"Clin. Trials"},{"key":"1705_CR8","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/ejhf.2675","volume":"24","author":"A Bayes-Genis","year":"2022","unstructured":"Bayes-Genis, A. et al. Biomarkers in heart failure clinical trials. A review from the Biomarkers Working Group of the Heart Failure Association of the European Society of Cardiology. Eur. J. Heart Fail. 24, 1767\u20131777 (2022).","journal-title":"Eur. J. Heart Fail."},{"key":"1705_CR9","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/520030a","volume":"520","author":"S bookS Metaphor","year":"2015","unstructured":"bookS Metaphor, S. & StatiSticS, A. Time for one-person trials. Nature 520, 30 (2015).","journal-title":"Nature"},{"key":"1705_CR10","doi-asserted-by":"crossref","unstructured":"Ling, Y., Upadhyaya, P., Chen, L., Jiang, X. & Kim, Y. Emulate Randomized Clinical Trials using Heterogeneous Treatment Effect Estimation for Personalized Treatments: Methodology Review and Benchmark. J. Biomed. Inform. 104256 (2022).","DOI":"10.1016\/j.jbi.2022.104256"},{"key":"1705_CR11","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s10654-017-0293-4","volume":"32","author":"JA Labrecque","year":"2017","unstructured":"Labrecque, J. A. & Swanson, S. A. Target trial emulation: teaching epidemiology and beyond. Eur. J. Epidemiol. 32, 473\u2013475 (2017).","journal-title":"Eur. J. Epidemiol."},{"key":"1705_CR12","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1093\/aje\/kwv254","volume":"183","author":"MA Hern\u00e1n","year":"2016","unstructured":"Hern\u00e1n, M. A. & Robins, J. M. Using big data to emulate a target trial when a randomized trial is not available. Am. J. Epidemiol. 183, 758\u2013764 (2016).","journal-title":"Am. J. Epidemiol."},{"key":"1705_CR13","doi-asserted-by":"crossref","unstructured":"Matthews A. A., Danaei G., Islam N., Kurth T. Target trial emulation: applying principles of randomised trials to observational studies. BMJ 378, e071108 (2022).","DOI":"10.1136\/bmj-2022-071108"},{"key":"1705_CR14","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.cjca.2021.05.012","volume":"37","author":"SA Kutcher","year":"2021","unstructured":"Kutcher, S. A., Brophy, J. M., Banack, H. R., Kaufman, J. S. & Samuel, M. Emulating a randomised controlled trial with observational data: an introduction to the target trial framework. Can. J. Cardiol. 37, 1365\u20131377 (2021).","journal-title":"Can. J. Cardiol."},{"key":"1705_CR15","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1097\/EDE.0000000000001308","volume":"32","author":"R Lenain","year":"2021","unstructured":"Lenain, R. et al. Clinical trial emulation by matching time-dependent propensity scores: the example of estimating impact of kidney transplantation. Epidemiology 32, 220\u2013229 (2021).","journal-title":"Epidemiology"},{"key":"1705_CR16","doi-asserted-by":"publisher","first-page":"e213845","DOI":"10.1001\/jamanetworkopen.2021.3845","volume":"4","author":"RH Groenwold","year":"2021","unstructured":"Groenwold, R. H. Trial emulation and real-world evidence. JAMA Netw. Open 4, e213845\u2013e213845 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1705_CR17","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1002\/cpt.1793","volume":"107","author":"JM Franklin","year":"2020","unstructured":"Franklin, J. M., Glynn, R. J., Suissa, S. & Schneeweiss, S. Emulation differences versus biases when calibrating RWE findings against RCTs. Clin. Pharmacol. Ther.107, 735 (2020).","journal-title":"Clin. Pharmacol. Ther."},{"key":"1705_CR18","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1001\/jama.2023.4221","volume":"329","author":"SV Wang","year":"2023","unstructured":"Wang, S. V. et al. Emulation of randomized clinical trials with nonrandomized database analyses: results of 32 clinical trials. JAMA 329, 1376\u20131385 (2023).","journal-title":"JAMA"},{"key":"1705_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40537-021-00516-9","volume":"8","author":"T Emmanuel","year":"2021","unstructured":"Emmanuel, T. et al. A survey on missing data in machine learning. J. Big Data 8, 1\u201337 (2021).","journal-title":"J. Big Data"},{"key":"1705_CR20","unstructured":"Marlin B. M. Missing data problems in machine learning. (2008)."},{"key":"1705_CR21","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.artmed.2010.05.002","volume":"50","author":"JM Jerez","year":"2010","unstructured":"Jerez, J. M. et al. Missing data imputation using statistical and machine learning methods in a real breast cancer problem. Artif. Intell. Med. 50, 105\u2013115 (2010).","journal-title":"Artif. Intell. Med."},{"key":"1705_CR22","unstructured":"Lakshminarayan K., Harp S. A., Goldman R. P., Samad T. Imputation of missing data using machine learning techniques. In: Proc. Second International Conference on Knowledge Discovery and Data Mining KDD'96 (1996)."},{"key":"1705_CR23","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/713827181","volume":"17","author":"GE Batista","year":"2003","unstructured":"Batista, G. E. & Monard, M. C. An analysis of four missing data treatment methods for supervised learning. Appl. Artif. Intell. 17, 519\u2013533 (2003).","journal-title":"Appl. Artif. Intell."},{"key":"1705_CR24","unstructured":"Richman M. B., Trafalis T. B., Adrianto I. Missing data imputation through machine learning algorithms. In: Artificial Intelligence Methods in the Environmental Sciences (Springer, 2009)."},{"key":"1705_CR25","first-page":"1","volume":"18","author":"D Bertsimas","year":"2018","unstructured":"Bertsimas, D., Pawlowski, C. & Zhuo, Y. D. From predictive methods to missing data imputation: an optimization approach. J. Mach. Learn. Res. 18, 1\u201339 (2018).","journal-title":"J. Mach. Learn. Res."},{"key":"1705_CR26","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s42256-020-00276-w","volume":"3","author":"R Liu","year":"2021","unstructured":"Liu, R., Wei, L. & Zhang, P. A deep learning framework for drug repurposing via emulating clinical trials on real-world patient data. Nat. Mach. Intell. 3, 68\u201375 (2021).","journal-title":"Nat. Mach. Intell."},{"key":"1705_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43929-1","volume":"14","author":"C Zang","year":"2023","unstructured":"Zang, C. et al. High-throughput target trial emulation for Alzheimer\u2019s disease drug repurposing with real-world data. Nat. Commun. 14, 8180 (2023).","journal-title":"Nat. Commun."},{"key":"1705_CR28","doi-asserted-by":"crossref","unstructured":"Zong, N. et al. BETA: a comprehensive benchmark for computational drug-target prediction. Brief. Bioinform. 23, 1\u201316 (2022).","DOI":"10.1093\/bib\/bbac199"},{"key":"1705_CR29","doi-asserted-by":"crossref","unstructured":"Honap S., Danese S., Peyrin-Biroulet L. Target trial emulation: improving the quality of observational studies in inflammatory bowel disease using the principles of randomized trials. Inflamm. Bowel Dis. 31, 843\u2013849 (2024).","DOI":"10.1093\/ibd\/izae131"},{"key":"1705_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12874-023-02000-9","volume":"23","author":"G Scola","year":"2023","unstructured":"Scola, G. et al. Implementation of the trial emulation approach in medical research: a Scoping review. BMC Med. Res. Methodol. 23, 186 (2023).","journal-title":"BMC Med. Res. Methodol."},{"key":"1705_CR31","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.2217\/cer-2020-0161","volume":"9","author":"KM Sheffield","year":"2020","unstructured":"Sheffield, K. M., Dreyer, N. A., Murray, J. F., Faries, D. E. & Klopchin, M. N. Replication of randomized clinical trial results using real-world data: paving the way for effectiveness decisions. J. Comp. Effect. Res. 9, 1043\u20131050 (2020).","journal-title":"J. Comp. Effect. Res."},{"key":"1705_CR32","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1053\/j.ajkd.2023.07.024","volume":"83","author":"J-I Shin","year":"2024","unstructured":"Shin, J.-I. & Grams, M. E. Trial emulation methods. Am. J. Kidney Dis. 83, 264\u2013267 (2024).","journal-title":"Am. J. Kidney Dis."},{"key":"1705_CR33","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-00680-8","volume":"8","author":"Y Luo","year":"2017","unstructured":"Luo, Y. et al. A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nat. Commun. 8, 573 (2017).","journal-title":"Nat. Commun."},{"key":"1705_CR34","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1093\/bib\/bbz147","volume":"22","author":"N Zong","year":"2021","unstructured":"Zong, N. et al. Drug\u2013target prediction utilizing heterogeneous bio-linked network embeddings. Brief. Bioinform. 22, 568\u2013580 (2021).","journal-title":"Brief. Bioinform."},{"key":"1705_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1093\/bioinformatics\/bty543","volume":"35","author":"F Wan","year":"2019","unstructured":"Wan, F., Hong, L., Xiao, A., Jiang, T. & Zeng, J. NeoDTI: neural integration of neighbor information from a heterogeneous network for discovering new drug\u2013target interactions. Bioinformatics 35, 104\u2013111 (2019).","journal-title":"Bioinformatics"},{"key":"1705_CR36","doi-asserted-by":"crossref","unstructured":"Huang, K. et al. Deep Purpose: a deep learning library for drug\u2013target interaction prediction. Bioinformatics, 36, 5545\u20135547 (2020).","DOI":"10.1093\/bioinformatics\/btaa1005"},{"key":"1705_CR37","doi-asserted-by":"publisher","first-page":"i821","DOI":"10.1093\/bioinformatics\/bty593","volume":"34","author":"H \u00d6zt\u00fcrk","year":"2018","unstructured":"\u00d6zt\u00fcrk, H., \u00d6zg\u00fcr, A. & Ozkirimli, E. DeepDTA: deep drug\u2013target binding affinity prediction. Bioinformatics 34, i821\u2013i829 (2018).","journal-title":"Bioinformatics"},{"key":"1705_CR38","doi-asserted-by":"crossref","unstructured":"Nguyen, T., Le, H. & Venkatesh, S. GraphDTA: prediction of drug\u2013target binding affinity using graph convolutional networks. Bioinformatics, 37, 1140\u20131147 (2019).","DOI":"10.1093\/bioinformatics\/btaa921"},{"key":"1705_CR39","doi-asserted-by":"publisher","first-page":"e213587","DOI":"10.1001\/jamanetworkopen.2021.3587","volume":"4","author":"DJ Boyne","year":"2021","unstructured":"Boyne, D. J. et al. Association of a shortened duration of adjuvant chemotherapy with overall survival among individuals with stage III colon cancer. JAMA Netw. Open 4, e213587\u2013e213587 (2021).","journal-title":"JAMA Netw. Open"},{"key":"1705_CR40","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1177\/1740774511420743","volume":"9","author":"MA Hern\u00e1n","year":"2012","unstructured":"Hern\u00e1n, M. A. & Hern\u00e1ndez-D\u00edaz, S. Beyond the intention-to-treat in comparative effectiveness research. Clin. Trials 9, 48\u201355 (2012).","journal-title":"Clin. Trials"},{"key":"1705_CR41","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1111\/nep.13709","volume":"25","author":"G Tripepi","year":"2020","unstructured":"Tripepi, G., Chesnaye, N. C., Dekker, F. W., Zoccali, C. & Jager, K. J. Intention to treat and per protocol analysis in clinical trials. Nephrology 25, 513\u2013517 (2020).","journal-title":"Nephrology"},{"key":"1705_CR42","doi-asserted-by":"crossref","unstructured":"Sedgwick P. Intention to treat analysis versus per protocol analysis of trial data. BMJ 350, (2015).","DOI":"10.1136\/bmj.h681"},{"key":"1705_CR43","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1177\/1740774516634335","volume":"13","author":"EJ Murray","year":"2016","unstructured":"Murray, E. J. & Hern\u00e1n, M. A. Adherence adjustment in the Coronary Drug Project: a call for better per-protocol effect estimates in randomized trials. Clin. Trials 13, 372\u2013378 (2016).","journal-title":"Clin. Trials"},{"key":"1705_CR44","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.cardfail.2021.01.022","volume":"27","author":"B Bozkurt","year":"2021","unstructured":"Bozkurt, B. et al. Universal definition and classification of heart failure: a report of the heart failure society of America, heart failure association of the European society of cardiology, Japanese heart failure society and writing committee of the universal definition of heart failure. J. Card. Fail. 27, 387\u2013413 (2021).","journal-title":"J. Card. Fail."},{"key":"1705_CR45","first-page":"393","volume":"2","author":"SM Dunlay","year":"2009","unstructured":"Dunlay, S. M. et al. Prognostic value of biomarkers in heart failure: application of novel methods in the community. Circulation: Heart Fail. 2, 393\u2013400 (2009).","journal-title":"Circulation: Heart Fail."},{"key":"1705_CR46","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1016\/j.jacc.2023.03.393","volume":"81","author":"MM Kittleson","year":"2023","unstructured":"Kittleson, M. M. et al. 2023 ACC Expert Consensus decision pathway on management of heart failure with preserved ejection fraction: a report of the American College of Cardiology Solution Set Oversight Committee. J. Am. Coll. Cardiol. 81, 1835\u20131878 (2023).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1705_CR47","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich, P. A. et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 79, e263\u2013e421 (2022).","journal-title":"J. Am. Coll. Cardiol."},{"key":"1705_CR48","doi-asserted-by":"crossref","unstructured":"Pi\u00f1ero, J. et al. DisGeNET: a comprehensive platform integrating information on human disease-associated genes and variants. Nucleic Acids Res. gkw943 (2016).","DOI":"10.1093\/nar\/gkw943"},{"key":"1705_CR49","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1002\/jcp.29889","volume":"236","author":"Y Xu","year":"2021","unstructured":"Xu, Y., Rong, J. & Zhang, Z. The emerging role of angiotensinogen in cardiovascular diseases. J. Cell. Physiol. 236, 68\u201378 (2021).","journal-title":"J. Cell. Physiol."},{"key":"1705_CR50","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1111\/obr.12828","volume":"20","author":"I Warbrick","year":"2019","unstructured":"Warbrick, I. & Rabkin, S. W. Hypoxia-inducible factor 1-alpha (HIF-1\u03b1) as a factor mediating the relationship between obesity and heart failure with preserved ejection fraction. Obes. Rev. 20, 701\u2013712 (2019).","journal-title":"Obes. Rev."},{"key":"1705_CR51","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1056\/NEJMoa1409077","volume":"371","author":"JJ McMurray","year":"2014","unstructured":"McMurray, J. J. et al. Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure. N. Engl. J. Med. 371, 993\u20131004 (2014).","journal-title":"N. Engl. J. Med."},{"key":"1705_CR52","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.cmet.2009.05.005","volume":"9","author":"J Krishnan","year":"2009","unstructured":"Krishnan, J. et al. Activation of a HIF1\u03b1-PPAR\u03b3 axis underlies the integration of glycolytic and lipid anabolic pathways in pathologic cardiac hypertrophy. Cell Metab. 9, 512\u2013524 (2009).","journal-title":"Cell Metab."},{"key":"1705_CR53","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1056\/NEJMsr1809937","volume":"381","author":"Investigators","year":"2019","unstructured":"Investigators AoURP. The \u201cAll of Us\u201d research program. N. Engl. J. Med. 381, 668\u2013676 (2019).","journal-title":"N. Engl. J. Med."},{"key":"1705_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s41666-020-00082-4","volume":"5","author":"J Xu","year":"2021","unstructured":"Xu, J. et al. Federated learning for healthcare informatics. J. Healthc. Inform. Res. 5, 1\u201319 (2021).","journal-title":"J. Healthc. Inform. Res."},{"key":"1705_CR55","first-page":"1","volume":"13","author":"Q Yang","year":"2019","unstructured":"Yang, Q. et al. Federated learning. Synth. Lect. Artif. Intell. Mach. Learn. 13, 1\u2013207 (2019).","journal-title":"Synth. Lect. Artif. Intell. Mach. Learn."},{"key":"1705_CR56","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1136\/amiajnl-2014-002747","volume":"21","author":"RL Fleurence","year":"2014","unstructured":"Fleurence, R. L. et al. Launching PCORnet, a national patient-centered clinical research network. J. Am. Med. Inform. Assoc. 21, 578\u2013582 (2014).","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"1705_CR57","doi-asserted-by":"publisher","first-page":"S63","DOI":"10.3122\/jabfm.2015.S1.150133","volume":"28","author":"M Cifuentes","year":"2015","unstructured":"Cifuentes, M. et al. Electronic health record challenges, workarounds, and solutions observed in practices integrating behavioral health and primary care. J. Am. Board Fam. Med. 28, S63\u2013S72 (2015).","journal-title":"J. Am. Board Fam. Med."},{"key":"1705_CR58","first-page":"572","volume":"42","author":"M Reisman","year":"2017","unstructured":"Reisman, M. EHRs: the challenge of making electronic data usable and interoperable. Pharm. Ther. 42, 572 (2017).","journal-title":"Pharm. Ther."},{"key":"1705_CR59","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1016\/j.bbadis.2012.12.014","volume":"1832","author":"HK Gaggin","year":"2013","unstructured":"Gaggin, H. K. & Januzzi, J. L. Jr. Biomarkers and diagnostics in heart failure. Biochim. Biophys. Acta (BBA)-Mol. Basis Dis. 1832, 2442\u20132450 (2013).","journal-title":"Biochim. Biophys. Acta (BBA)-Mol. Basis Dis."},{"key":"1705_CR60","unstructured":"Gaggin H. K., Januzzi J. L. Update|cardiac biomarkers and heart failure. Latest Cardiol. (2023)."},{"key":"1705_CR61","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.jclinepi.2009.11.020","volume":"63","author":"D Westreich","year":"2010","unstructured":"Westreich, D., Lessler, J. & Funk, M. J. Propensity score estimation: neural networks, support vector machines, decision trees (CART), and meta-classifiers as alternatives to logistic regression. J. Clin. Epidemiol. 63, 826\u2013833 (2010).","journal-title":"J. Clin. Epidemiol."}],"container-title":["npj Digital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01705-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01705-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01705-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T20:02:42Z","timestamp":1748116962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41746-025-01705-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1705"],"URL":"https:\/\/doi.org\/10.1038\/s41746-025-01705-z","relation":{},"ISSN":["2398-6352"],"issn-type":[{"value":"2398-6352","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"29 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"306"}}